Acetylsalicylic acid Active Not Recruiting Phase 4 Trials for Diseased Saphenous Vein Grafts Prevention

IndicationsStatusPurposePhase
Active Not RecruitingPrevention4
clinicaltrials.gov IdentifierTitleDrugs
NCT02053909Ticagrelor Antiplatelet Therapy to Reduce Graft Events and Thrombosis